Process for manufacturing morpholino-nucleotides, and use...

Organic compounds -- part of the class 532-570 series – Organic compounds – Chalcogen in the nitrogen containing substituent

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C536S018700, C536S022100, C536S023100, C536S025300, C536S026600, C536S028100, C536S028600, C536S055300, C536S026100, C544S242000, C544S066000, C544S180000, C544S224000, C544S233000, C544S235000

Reexamination Certificate

active

07105661

ABSTRACT:
The invention relates to the use of morpholino-nucleosides of formula:in which R1represents a nucleic base and R2represents a group corresponding to one of the following formulae:in-line-formulae description="In-line Formulae" end="lead"?—(CH2)n—NH2—(CH2)n—SHin-line-formulae description="In-line Formulae" end="tail"?in-line-formulae description="In-line Formulae" end="lead"?—(CH2)n—COOH —(CH2)n—OHin-line-formulae description="In-line Formulae" end="tail"?in-line-formulae description="In-line Formulae" end="lead"?—(CH2)n—NH—R3—(CH2)n—SR3in-line-formulae description="In-line Formulae" end="tail"?in-line-formulae description="In-line Formulae" end="lead"?—(CH2)n—CO—R3—(CH2)n—OR3in-line-formulae description="In-line Formulae" end="tail"?in which n is an interger ranging from 1 to 12 and R3is a group derived from a label, from a protein, from an enzyme, from a fatty acid or from a peptide, as chain terminators in a process of DNA or RNA sequencing by the Sanger method, or for the labelling of DNA or RNA fragments.

REFERENCES:
patent: 4515781 (1985-05-01), Torrence et al.
patent: 5721341 (1998-02-01), Molko et al.
patent: 5849482 (1998-12-01), Meyer, Jr. et al.
patent: 6365577 (2002-04-01), Iversen
patent: 6838560 (2005-01-01), Marciacq et al.
patent: 93 10864 (1993-09-01), None
patent: WO 95/07907 (1995-03-01), None
patent: WO 96/23807 (1996-08-01), None
Gregory, Martha R.,et al., “Inactivation of Phosphofructokinase by Dialdehyde-ATP”, Archives of Biochemistry and Biophysics, 196(1):199-208 (1979).
Agrawal, S., et al., “Efficient Methods for Attaching Non-Radioactive Labels to the 5′ Ends of Synthetic Oligodeoxyribonucleotides”, Nucleic Acids Research, vol. 14, No. 15: pp. 6227-6245; 1986.
Broker, T.R., et al., “Electron Microscopic Visualization of tRNA Genes with Ferritin-Avidin: Biotin Labels”, Nucleic Acids Research, vol. 5, No. 2: pp. 363-385; 1978.
Girault, Isabelle, et al., “Use of Morpholinonucleotides to Conjugate Oxidized DNA Bases to Proteins”, Bioconjugate Chem., vol. 7: pp. 445-450; 1996, XP002121979.
Hileman, R.E., et al., “Synthesis and Characterization of Conjugates Formed Between Periodate-Oxidized Ribonucleotides and Amine-Containing Fluorophores”, Bioconjugate Chem., vol. 5, No. 5: pp. 436-444; 1994.
Lundwig, J., et al., “Rapid and Efficient Synthesis of Nucleoside 5'-O-(1-Thiotriphosphates), 5'- Triphosphates and 2', 3'-Cyclophosphorothioates Using 2-Chloro-4H-1,3,2-benzodioxaphosphorin-4-one”, Journal of Organic Chemistry, vol. 54; pp. 631-635; 1989.
Rayford, Richard, et al., “Reductive Alkylation with Oxidized Nucleotides: Use in Affinity Labeling or Affinity Chromatography”, J. Biol. Chem, vol. 260, No. 29: pp. 15708-15713; 1985.
Sanger, F., et al. “DNA Sequencing with Chain-Terminating Inhibitors”, Proc. Natl. Acad. Sci. USA, vol. 74, No. 12: pp. 5463-5467; 1977, London.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Process for manufacturing morpholino-nucleotides, and use... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process for manufacturing morpholino-nucleotides, and use..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for manufacturing morpholino-nucleotides, and use... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3604246

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.